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PURPOSE. Many genome-wide association studies have identified common single nucleotide
polymorphisms (SNPs) at the 9p21 glaucoma locus (CDKN2B/CDKN2B-AS1) to be significantly
associated with primary open-angle glaucoma (POAG), with association being stronger in
normal tension glaucoma (NTG) and advanced glaucoma. We aimed to determine whether any
observed differences in genetic association at the 9p21 locus are influenced by sex.
METHODS. Sex was assessed as a risk factor for POAG for 2241 glaucoma participants from the
Australian and New Zealand Registry of Advanced Glaucoma, the Glaucoma Inheritance Study
in Tasmania, and the Flinders Medical Centre. A total of 3176 controls were drawn from the
Blue Mountains Eye Study and South Australia: 1523 advanced POAG and 718 nonadvanced
POAG cases were genotyped along with 3176 controls. We selected 13 SNPs at the 9p21
locus, and association results were subanalyszd by sex for high-tension glaucoma (HTG) and
NTG. Odds ratios (ORs) between sexes were compared.
RESULTS. A sex bias was present within advanced NTG cases (57.1% female versus 42.9% male, P
¼ 0.0026). In all POAG cases, the strongest associated SNP at 9p21 was rs1063192 (OR, 1.43; P
¼ 4 3 1018). This association was stronger in females (OR, 1.5; P ¼ 5 3 1013) than in males
(OR, 1.35; P ¼ 7 3 107), with a statistically significant difference in female to male OR
comparison (P ¼ 1.0 3 102). An NTG to HTG subanalysis yielded statistically significant
results only in females (OR, 1.63; P ¼ 1.53 104) but not in males (OR, 1.15; P ¼ 2.83 101),
with a statistically significant difference in female to male OR comparison (P ¼ 1.4 3 104).
CONCLUSIONS. This study demonstrated that female sex is a risk factor for developing advanced
NTG. The stronger genetic signals at the 9p21 locus among females may contribute at least in
part to the observed sex bias for NTG.
Keywords: 9p21, primary open-angle glaucoma, normal-tension glaucoma, sex specific, sex bias
Primary open-angle glaucoma (POAG) is the most commontype of glaucoma and is characterized pathologically by a
progressive loss of retinal ganglion cells with corresponding
loss of visual field. The prevalence of POAG in the age group
over 40 years is estimated to be 2%–3% among Caucasian
populations,1–3 approximately 6%–7% among Black popula-
tions,4,5 and 3.9% among the Japanese.6
Although demographic factors such as older age and black
race are well known to be associated with an increased risk for
POAG, there is no consensus with regards to sex as a risk factor.
Results from previous large population-based studies have been
inconsistent, with some studies reporting higher prevalence in
females,5,7 whereas others showed higher prevalence in
males8,9 or no association at all.10–13 The Collaborative
Normal-Tension Glaucoma Study Group reported female sex
as an independent risk factor for disease progression in normal-
tension glaucoma (NTG), a subtype of POAG with no recorded
intraocular pressure (IOP) elevation (21 mm Hg).14 A recent
meta-analysis, however, reported greater POAG prevalence
among males in comparison to age-matched females.15
There are obvious biological and physiological differences
between males and females, and these differences are known to
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affect the incidence and progression of various common
diseases in human, notably cardiovascular and autoimmune
diseases.16 These sex differences have typically been attributed
to the differences in the sex hormone levels between males
and females and the genetic contribution of the sex
chromosomes (chromosome X).17 In glaucoma, there is
evidence suggesting that the risk of POAG among females
may be influenced by estrogen metabolism and estrogen
exposure, both endogenously and exogenously.18–20
More recently, the autosomes, shared by both males and
females, were also shown to contribute significantly to sex-
specific disease differences due to sexual dimorphism in gene
regulation and expression between sexes.21 The dimorphism
in the regulation and expression of genes is likely to explain
part of the difference in a gene–environment interaction and
also influence phenotypic traits in terms of sex-specific
susceptibility to disease.16
With the advent of genome-wide association studies
(GWASs), single nucleotide polymorphisms (SNPs) associated
with a disease, particularly known to have sex-specific
differences, can be systematically analyzed in depth to detect
whether disease association is stronger in one sex than the
other.22 For instance, certain SNPs in the RELN gene were
shown to have significant association for schizophrenia and
bipolar disorder in females but not in males.23,24 POAG is a
genetically complex disease, and recent GWASs identified
several SNPs within the CDKN2B/CDKN2B-AS1 genes on
chromosome 9p21 to have strong and reproducible association
especially with the NTG subtype.25–27 These previous studies
did not specifically analyze the association of sex among the
SNPs relevant to POAG. In this study, we aim to investigate this




All participants provided written informed consent, and
approval was obtained from the Human Research Ethics
Committees of Southern Adelaide Health Service/Flinders
University, University of Tasmania and University of Sydney.
The study adhered to the tenets of the Declaration of Helsinki.
Participants were drawn from the Australian & New Zealand
Registry of Advanced Glaucoma, the Glaucoma Inheritance
Study in Tasmania, the Blue Mountains Eye Study (BMES, a
population-based study of residents 49 years of age and older
living in the Blue Mountains region west of Sydney), and
patients attending eye clinics at Flinders Medical Centre,
Adelaide, Australia. All participants were Australian of Europe-
an descent. The cohorts and clinical definitions are as
described in detail in earlier reports.25,28,29
Briefly, advanced glaucoma was defined by severe visual
loss resulting from POAG. This included best-corrected visual
acuity worse than 6/60 resulting from POAG or a reliable 24-2
Humphrey Visual Field with a mean deviation (MD) of worse
than 22db or at least two of four central fixation squares
affected with a pattern standard deviation of less than 0.5%.
The field loss had to be the result of POAG, and the less
severely affected eye also was also required to have signs of
glaucomatous disc damage. Less severe or nonadvanced
glaucoma was defined by concordant findings of typical
glaucomatous visual field defects on the Humphrey 24-2 test,
with corresponding optic disc rim thinning, including an
enlarged vertical cup-to-disc ratio (VCDR) (‡0.7) or VCDR
asymmetry (‡0.2) between the two eyes. The age at glaucoma
diagnosis, highest recorded IOP, central corneal thickness
(CCT), and MD in each eye were obtained from the medical
records. For each variable (IOP, CCT, MD, and VCDR), the data
from the worse eye were used. Any participants without sex or
genotype data were excluded. Participants with any form of
secondary glaucoma or mutations in the myocilin gene were
also excluded.
Controls were drawn from the BMES and unaffected
participants from South Australia.28 All controls were exam-
ined and found to have no sign of glaucoma. A total of 2742
elderly participants from the BMES and 434 participants from
South Australia were included. Parameters obtained from the
controls included age, genotype data, IOP, CCT, and VCDR.
Genotyping and Association Analysis
Genotyping of the 13 SNPs at the 9p21 locus has been described
previously.25,28 The SNPs chosen were those from our previous
GWASs and from targeted genotyping at the 9p21 locus. Briefly,
samples used in the discovery phase of the reported GWAS were
genotyped on the Human1M-Omni array (Illumina, Inc., San
Diego, CA, USA), and samples used in the replication phase of the
GWAS were typed on the MassArray platform (Sequenom, Inc.,
San Diego, CA, USA). The controls were genotyped on Illumina
HumanHap 610W Quad and Illumina Human670Quad Bead
arrays (BMES) or by MassArray (others).
Data including sex, age at diagnosis, highest recorded IOP,
POAG subtype (NTG or HTG), and CCT were gathered from
each participant where possible. Every SNP was analyzed for
genetic association. The genetic association analyses were
conducted using Plink (Plink version 1.07, 10 August 2009.
Purcell S. Available at: http://pngu.mgh.harvard.edu/purcell/
plink/. Accessed August 2015).30 Initial analyses were con-
ducted comparing POAG to controls in males, females, and
both sexes combined. The same analyses were then conducted
in advanced POAG cases only. We then ran separate association
analyses in advanced cases of NTG (IOP  21 mm Hg) and
HTG (IOP > 21 mm Hg) for each sex and combined. To test for
the effect of sex on the association at the 9p21 SNPs, the
obtained odds ratios (ORs) were compared between the sexes
by computing
T ¼ LogðORcasesÞ  logðORcontrolsÞ½ =variance LogðORcasesÞ½
logðORcontrolsÞ
¼ LogðORcasesÞ  logðORcontrolsÞ½ =
variance LogðORcasesÞ½  þ variance logðORcontrolsÞ½ f g:
P values were computed based on T following a v21
distribution. Using a Bonferroni correction, a P value of
0.004 was required to account for the multiple testing of the
13 SNPs (in practice, due to the correlation between these
SNPs, this threshold may be overconservative).
RESULTS
Overall, there were a total of 2241 cases of POAG and 3176
controls with sex and genotype data available. Among the
POAG cases, 1180 (52.66%) were females and 1061 (47.34%)
were males, whereas there were 1793 (56.5%) females to 1383
(43.5%) males among the controls (Table 1). The POAG cohort
had a mean age of glaucoma diagnosis of 60.6 6 14.3 years.
The mean highest documented IOP was 27.1 6 11.2 mm Hg,
with 66.8% having the highest recorded IOP of >21 mm Hg. A
total of 1523 (68%) were classified as having advanced disease,
with 744 (48.85%) males and 779 (51.15%) females (P¼ 0.37).
Details of the demographic data for both the POAG cohort and
controls are shown in Table 1. A notable sex bias was present
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within advanced NTG cases (57.1% female versus 42.9% male,
P¼ 0.0026), but not in HTG cases (48.1% female versus 51.9%
male, P ¼ 0.24; Table 2).
On association analysis conducted for all 13 SNPs of 9p21
among all POAG cases, 4 SNPs reached genome-wide
significance (P < 5 3 108): rs1063192 (P ¼ 3.76 3 1018),
rs4977756 (P¼ 1.973 1016), rs10120688 (P¼ 6.993 1011),
and rs3731239 (P ¼ 5.63 3 1010) (Supplementary Table).
Table 3 shows the association results stratified by sex for the
top four SNPs. The top three SNPs, namely rs1063192,
rs4977756, and rs10120688, reached genome-wide signifi-
cance only in females but not in males. The OR difference
between females and males was statistically significant for
rs1063192 (P¼ 1.043 102), rs4977756 (P¼ 1.373 104), and
rs3731239 (P ¼ 2.403 103) (Table 3).
A strong association was observed when the analyses were
conducted comparing only advanced cases to the controls
(Table 4). In females, the observed association was stronger in
the advanced cases than in overall POAG. This trend, however,
was not observed among the males, which showed compara-
ble ORs and significance levels in both advanced and overall
POAG cases (Table 4).
The NTG subgroup was then compared directly to the HTG
subgroup within advanced POAG, as this locus is known to be
more strongly associated with NTG than HTG.25,31 Three SNPs
(rs1063192, rs4977756, and rs10120688) showed statistically
significant association to NTG (when applying a conservative
Bonferroni correction for 13 tests at 9p21) when both sexes
were analyzed together. The risk allele A of SNP rs1063192
carries an OR of 1.40 (P ¼ 2.46 3 104) for developing NTG
(Table 5). Marked sex differences were again observed when
the analyses were conducted separately for females and males
(Table 5). Among the females, these SNPs were significantly
associated with NTG, yielding ORs of 1.63 for rs1063192, 1.60
for rs4977756, and 1.62 for rs10120688 (Table 5). On the other
hand, in males with NTG, these same SNPs carried weaker ORs
of 1.15 for rs1063192 and 1.22 for both rs4977756 and
rs10120688 and did not reach statistical significance. The OR
difference between females and males was statistically
significant (Tables 3 and 5).
DISCUSSION
The association between SNPs at chromosome 9p21 and POAG
has been widely established in multiple populations.25–28,31 As
previously noted, the association was significantly stronger
among the NTG subgroup and also among the advanced
blinding cases.25,32,33 Our current study highlights that the
strength of the association also varies markedly depending on
sex. The data consistently showed that the association of these
known glaucoma risk alleles at chromosome 9p21 with POAG
is stronger in females than in males. These sex differences in
the strength of association have not been previously reported
among SNPs at the 9p21 locus.
The differences in the strength of association between
sexes noticeably increased among the advanced POAG cases. It
is well recognized that POAG progresses with increasing age,
and therefore, the advanced cases are more frequently
documented among the older age group.15 Nevertheless, the
underlying reason for the observed stronger association of the
chromosome 9p21 risk alleles particularly among female
advanced POAG cases in comparison to the male counterpart
is unclear. Whether females with these risk alleles have higher
risk of progression to advanced POAG remains to be
elucidated. Also, the risk alleles of the three main SNPs,
rs1063192, rs4977756, and rs10120688, conferred a statisti-
cally significant OR ranging from 1.60 to 1.63 with NTG among
females only. The association with NTG did not reach statistical
significance among males, and the ORs were substantially
weaker (Table 5). The observation also suggests that this locus
may confer a greater risk for NTG among females.
TABLE 1. Demographics and Clinical Characteristics of the POAG
Cases and Controls
Variables
Mean 6 SD or N (%)
POAG Controls
Number, N 2241 3176
Males 1061 1383
Females 1180 1793
Age, y (P ¼ 0.4) 60.6 6 14.3 55.3 6 8.7
Males 59.5 6 14.9 55.1 6 8.5
Females 61.4 6 13.7 55.5 6 8.8
Female, N (%) 1180 (52.66%) 1793 (56.45%)
IOP, mm Hg 27.12 6 11.25 17.29 6 3.27
HTG, % 1084 (66.75%)
NTG, % 540 (33.25%)
VCDR 0.88 6 0.12 0.47 6 0.13
CCT, lm 518.0 6 40.2 532.7 6 84.4
F, female; M, male.
TABLE 2. Nonadvanced and Advanced POAG
Variables Male Female P Value Total
Nonadvanced POAG
N (%) 317 (44.15%) 401 (55.85%) 0.0017 718 (100%)
Age of diagnosis 67.3 6 13.2 62.9 6 12.5
IOP 25.0 6 9.5 24.8 6 8.3
VCDR 0.80 6 0.14 0.75 6 0.17
CCT 526.7 6 37.8 521.8 6 44.5
HTG, N (%) 120 (46.69%) 137 (53.31%) 0.29 257 (35.79%)
NTG, N (%) 34 (29.31%) 82 (70.69%) 8.2 3 106 116 (16.16%)
Advanced POAG
N (%) 744 (48.85%) 779 (51.15%) 0.37 1523 (100%)
Age of diagnosis 59.9 6 14.6 62.5 6 13.8
IOP 28.1 6 10.5 26.3 6 10.3
VCDR 0.92 6 0.08 0.90 6 0.09
CCT 516.1 6 41.4 516.3 6 39.0
HTG, N (%) 466 (51.95%) 431 (48.05%) 0.24 897 (58.90%)
NTG, N (%) 193 (42.89%) 257 (57.11%) 0.0026 450 (29.55%)
Sex Bias in Normal-Tension Glaucoma at 9p21 Glaucoma Locus IOVS j June 2016 j Vol. 57 j No. 7 j 3418
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/935339/ on 06/21/2017
Sex-specific differences in disease susceptibility, course,
and severity have long been known, notably in cardiovascu-
lar and autoimmune diseases. Several SNPs within chromo-
some 9p21 namely rs2383207, rs4977574, rs10757274,
rs10116277, and rs1333040 are also known to have
significant association with coronary heart disease.34,35 In
our current analyses (Supplementary Table), the SNP
rs2383207 conferred an OR of 1.39 (P ¼ 9.1 3 107) among
females and 1.19 (P¼ 1.43 102) among males for advanced
POAG, almost reaching the level of genome-wide significance
among females alone. The other four SNPs, however, did not
show any suggestive association with POAG, consistent with
previous studies.25–27 The lack of association between
relevant SNPs at chromosome 9p21 that confer risk for
POAG and those for cardiovascular diseases is in accordance
with the fact that there have been no clear association
between POAG and cardiovascular diseases.36,37
In POAG overall, sex influences have not been strongly
established previously. A recent meta-analysis by Tham et al.
reported greater prevalence among males, with an OR of 1.36
(95% confidence interval [CI], 1.23–1.52).15 Several studies
have also highlighted the protective effect of estrogen and
linked the risks of POAG among females with estrogen
metabolism and exposure.18–20 Lower IOP was shown to be
associated with postmenopausal hormonal use and pregnancy,
during which estrogen levels are elevated.18,38,39 Early
menopause (age less than 45 years)19 was associated with
increased risk of POAG, whereas later onset of menopause (age
more than 54 years) was associated with reduced risk.20 In the
BMES, later age of menarche was also found to be associated
with POAG.40 Pasquale et al., however, reported that later age
of menarche was associated with NTG only.41 Overall evidence
suggests that the risk of POAG is somehow inversely related to
the cumulative exposure of estrogen. Meta-analyzed GWAS data
also suggested an association between the estrogen SNPs
pathways and POAG among females.42 Although there are
several proposed hypotheses, the exact pathophysiology of any
putative protective effect of estrogen against POAG is still
unknown.
There may be other biological mechanisms underlying the
observed sex specificity such as epigenetic differences
between the sexes. Sexual dimorphism in gene regulation
and expression possibly mediates the differences in genotype–
environmental interactions, which could subsequently lead to
sex-specific susceptibility to POAG.16,21 Sex-genetic specificity
has been observed in several other diseases.43,44 In hyperten-
sion, angiotensin-converting enzyme DD genotypes were
significantly associated with hypertension in males only.43,44
In schizophrenia and bipolar disorder, SNPs in the RELN gene
were shown to have a significant association in females
only.23,24 The protein product of RELN, reelin is implicated
in neuronal migration and has been shown to be essential for
retinogeniculate targeting by retinal ganglion cells.45,46 Also,
the SNP rs7865618 on chromosome 9p21, known to have
significant association with coronary artery disease, was
recently shown to be male specific,22 explaining at least in
part the male bias in the incidence of coronary artery disease.47
One of the limitations of this study is that the result was
obtained from a single population cohort (Australian of
European descent). Our current study, however, comprises a
large number of both POAG cases (2241) and controls (3176),
and the analyses showed a notable sex difference in the
strength of association of glaucoma risk alleles at chromosome
9p21, especially in the NTG and advanced disease. Future
replication studies will confirm and strengthen these findings.
Second, some phenotypic data were not available from the
nonadvanced POAG group, and for a subset of the samples, we
used different genotyping methods that could potentially
introduce artifacts. However, the call rates (a good proxy for
genotyping accuracy) for the SNPs were high irrespective of
genotyping platform, and we believe our results to be robust.
Our previous publications on POAG used a mixture of







OR P 95% CI
Risk Allele Frequency
OR P 95% CICases Control Cases Control
rs1063192 0.655 0.558 1.50 4.73 3 1013 1.35–1.68 0.640 0.568 1.35 6.95 3 107 1.20–1.52 1.04 3 102
rs4977756 0.690 0.596 1.51 2.58 3 1013 1.35–1.69 0.667 0.608 1.29 2.72 3 105 1.15–1.45 1.37 3 104
rs10120688 0.564 0.481 1.40 5.86 3 109 1.25–1.56 0.547 0.495 1.23 1.05 3 103 1.09–1.39 2.40 3 103
rs3731239 0.691 0.623 1.35 6.63 3 107 1.20–1.53 0.694 0.639 1.28 2.29 3 104 1.12–1.46 2.35 3 101
TABLE 4. Association Analyses Comparing All POAG and Advanced POAG by Sex
SNPs
All POAG (N ¼ 2241) Advanced POAG (N ¼ 1523)
OR (95% CI) P Value OR (95% CI) P Value
Female, N (all): 1180, N (adv): 779
rs1063192 1.50 (1.34–1.68) 4.73 3 1013 1.64 (1.44–1.87) 6.97 3 1014
rs4977756 1.51 (1.35–1.69) 2.58 3 1013 1.69 (1.48–1.93) 1.14 3 1014
rs10120688 1.40 (1.25–1.56) 5.86 3 109 1.54 (1.35–1.75) 4.21 3 1011
rs3731239 1.35 (1.20–1.53) 6.63 3 107 1.40 (1.22–1.60) 1.13 3 106
Male, N (all): 1061, N (adv): 744
rs1063192 1.35 (1.20–1.52) 6.95 3 107 1.35 (1.18–1.54) 1.28 3 105
rs4977756 1.29 (1.15–1.45) 2.72 3 105 1.33 (1.16–1.53) 4.20 3 105
rs10120688 1.23 (1.09–1.39) 1.05 3 103 1.25 (1.09–1.43) 1.12 3 103
rs3731239 1.28 (1.12–1.46) 2.29 3 104 1.37 (1.19–1.59) 2.03 3 105
adv, advanced POAG; all, all POAG.
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genotyping methods, and those findings have now been
replicated by other groups,48 giving us confidence that our
findings here are robust. Third, the definition and diagnosis of
NTG is often difficult in a cross-sectional population. Many of
the diagnosed NTG patients would not have been subjected to
phasing; hence, the highest recorded IOP in a clinical setting
may not necessarily reflect the highest IOP.
In summary, the results of this study demonstrate a stronger
association of the POAG relevant SNPs at chromosome 9p21 in
females compared with males, particularly in the NTG and
advanced disease. This genetic association would at least in
part contribute to the observed significant sex bias for
advanced NTG. Although the exact reason underlying such
observations remains to be determined, we prompt other
researchers performing GWAS to conduct additional analyses
to specifically test for potential sex effects.
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